Core Insights - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications as of November 21, 2025, indicating ongoing interest in Hong Kong IPOs and full circulation of shares [1][2] Group 1: Companies Seeking Hong Kong IPOs - Dermavon Holdings Limited (德镁医药) is in the process of indirect overseas listing, with its application currently under review for supplementary materials [1][2] - Guangzhou Haote Energy Conservation Technology Co., Ltd. and Zhejiang Shimai Pharmaceutical Co., Ltd. are both pursuing direct overseas listings on the Hong Kong Stock Exchange [1][2] - Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Chengdu Canopus Robotics Technology Co., Ltd. are also applying for direct overseas listings [1][2] - Beijing Defeng New Journey Technology Co., Ltd. is seeking a direct overseas listing on the Hong Kong Stock Exchange [1][2] Group 2: Companies with Full Circulation Applications - Companies such as Youbao Online Technology Co., Ltd. and Yaojie Ankang (Nanjing) Technology Co., Ltd. have submitted applications for full circulation of shares, which have been received by the CSRC [1][2] - Other companies including Bama Tea Co., Ltd. and Shanghai Yingtai Medical Devices Co., Ltd. are also in the process of obtaining full circulation status [1][2] - Lianlian Digital Technology Co., Ltd. and Xuan Bamboo Biotechnology Co., Ltd. are among those seeking full circulation of shares on the Hong Kong Stock Exchange [1][2]